- €703.87m
- €1.10bn
- €201.35m
- 72
- 42
- 92
- 83
Annual income statement for Ascopiave SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 164 | 135 | 157 | 173 | 201 |
Cost of Revenue | |||||
Gross Profit | 162 | 133 | 165 | 181 | 185 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 135 | 101 | 125 | 127 | 150 |
Operating Profit | 29.2 | 33.8 | 31.9 | 46 | 51.6 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 49.3 | 55.3 | 38 | 41.6 | 49.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 58.7 | 45.3 | 31 | 36.6 | 36.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 58.7 | 45.3 | 32.7 | 36.2 | 35.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 58.7 | 45.3 | 32.7 | 36.2 | 35.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.275 | 0.214 | 0.089 | 0.157 | 0.16 |
Dividends per Share |